MMJ SA DE CV (USD)

Manufacturer adverse-event records for MMJ SA DE CV come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2016–2025 · thin-book · elevated Death-code · balanced

Volume signature

MMJ SA DE CV is a thinner MAUDE footprint

MMJ SA DE CV (USD) accounts for 6,502 FDA MAUDE reports (#319 of 434, thin-book tercile). Death-coded event_type share is 1.03% (elevated); Injury share 21.0% (balanced).

What the volume reading shows for MMJ SA DE CV (USD)

The standout signal for MMJ SA DE CV (USD) is filing volume: 6,502 adverse-event reports in FDA MAUDE (#319 of 434, thin-book). Death-coded event_type share sits at 1.03% (elevated).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 5,070 (78.0% of event_type total). Peak single-year volume reaches 1,409 reports across 10 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

6,502
Total Reports
67
Event-type Death
1,365
Injury Reports
20
Device Types

Event Types

Malfunction 5,070 (78.0%)
Injury 1,365 (21.0%)
Death 67 (1.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

4,967 (74.2%)
Required Intervention 1,156 (17.3%)
Other 243 (3.6%)
R 96 (1.4%)
Death 68 (1.0%)
O 53 (0.8%)
Life Threatening 42 (0.6%)
L 24 (0.4%)
Hospitalization 18 (0.3%)
H 12 (0.2%)
D 6 (0.1%)
Congenital Anomaly 4 (0.1%)
S 2 (0.0%)

Yearly Trend

16
2016: 1
17
2017: 513
18
2018: 321
19
2019: 589
20
2020: 679
21
2021: 786
22
2022: 1,030
23
2023: 1,072
24
2024: 1,409
25
2025: 102